Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$328M |
| 2 |
Johnson & Johnson
JNJ
|
+$229M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Target
TGT
|
+$155M |
| 5 |
Walt Disney
DIS
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$283M |
| 2 |
Eli Lilly
LLY
|
+$211M |
| 3 |
Microsoft
MSFT
|
+$199M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$184M |
| 5 |
Citigroup
C
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.03% |
| 2 | Healthcare | 12.1% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Consumer Staples | 11.92% |
| 5 | Industrials | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NXTM
2051
DELISTED
NxStage Medical Inc.
NXTM
| $916K | ﹤0.01% |
69,600
-62,700
| -47% | -$822K |
|
2052
Ameris Bancorp
ABCB
$5.88B
| $915K | ﹤0.01% |
49,800
+11,700
| +31% | +$221K |
|
2053
Acme United Corp
ACU
$214M
| $913K | ﹤0.01% |
60,500
+3,000
| +5% | +$41.6K |
|
2054
China Yuchai International
CYD
$1.81B
| $911K | ﹤0.01% |
+38,314
| New | +$748K |
|
|
ANCX
2055
DELISTED
Access National Corp
ANCX
| $911K | ﹤0.01% |
63,900
-16,300
| -20% | -$238K |
|
|
AFSI
2056
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $909K | ﹤0.01% |
46,612
-113,460
| -71% | -$2.11M |
|
2057
UTStarcom
UTSI
$23.3M
| $907K | ﹤0.01% |
82,474
+2,050
| +3% | +$22K |
|
2058
Clearwater Paper
CLW
$341M
| $898K | ﹤0.01% |
+18,800
| New | +$912K |
|
|
TULP
2059
Bloomia Holdings
TULP
$15.6M
| $897K | ﹤0.01% |
47,957
+7,028
| +17% | +$122K |
|
|
INWK
2060
DELISTED
InnerWorkings, Inc.
INWK
| $897K | ﹤0.01% |
+91,312
| New | +$999K |
|
|
CCIH
2061
DELISTED
Chinacache International Holdings Ltd
CCIH
| $897K | ﹤0.01% |
150,800
-11,500
| -7% | -$54.7K |
|
2062
Peapack-Gladstone Financial
PGC
$815M
| $894K | ﹤0.01% |
48,197
+12,597
| +35% | +$226K |
|
|
NOVB
2063
DELISTED
NORTH VALLEY BANCORP-COM
NOVB
| $892K | ﹤0.01% |
47,180
+19,400
| +70% | +$350K |
|
2064
E.W. Scripps
SSP
$259M
| $890K | ﹤0.01% |
54,660
-344,974
| -86% | -$4.97M |
|
2065
W.P. Carey
WPC
$16.9B
| $884K | ﹤0.01% |
13,950
-235,582
| -94% | -$15.5M |
|
2066
Crown Crafts
CRWS
$31.7M
| $881K | ﹤0.01% |
122,100
+17,817
| +17% | +$122K |
|
|
RELV
2067
DELISTED
Reliv International Inc
RELV
| $874K | ﹤0.01% |
47,671
+871
| +2% | +$13.2K |
|
2068
Flexsteel Industries
FLXS
$301M
| $869K | ﹤0.01% |
34,800
+15,500
| +80% | +$375K |
|
|
ASFI
2069
DELISTED
Asta Funding Inc
ASFI
| $869K | ﹤0.01% |
97,800
-5,200
| -5% | -$45.4K |
|
|
MERU
2070
DELISTED
MERU NETWORKS INC COM STK (DE)
MERU
| $869K | ﹤0.01% |
265,600
-1,100
| -0.4% | -$4.28K |
|
2071
MACOM Technology Solutions
MTSI
$19B
| $865K | ﹤0.01% |
50,800
+21,300
| +72% | +$338K |
|
|
NW.PRC.CL
2072
DELISTED
Natwest Bank Ads Series C
NW.PRC.CL
| $865K | ﹤0.01% |
34,525
+8,854
| +34% | +$222K |
|
|
CLVS
2073
DELISTED
Clovis Oncology, Inc.
CLVS
| $863K | ﹤0.01% |
14,200
-7,200
| -34% | -$511K |
|
2074
Veeco
VECO
$2.95B
| $862K | ﹤0.01% |
+23,160
| New | +$810K |
|
2075
TAT Technologies
TATT
$530M
| $857K | ﹤0.01% |
106,600
+3,200
| +3% | +$23.2K |
|
Similar funds
Renaissance Technologies's Q3 2013 Portfolio in Review
As of Q3 2013, Renaissance Technologies held 3,196 positions worth $41.2B, up 8.1% from $38.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q3 2013 filing shows 439 new, 1,284 increased, 1,031 reduced and 412 closed positions. Its largest new stake was GE Aerospace: 1,361,721 shares worth $156M. The largest sale was Apple, an estimated $283M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q3 2013 buy was GE Aerospace: 1,361,721 shares worth $156M.
- Renaissance Technologies added most to IBM in Q3 2013, an estimated $328M increase.
- Renaissance Technologies's biggest Q3 2013 reduction was Eli Lilly, cutting an estimated $211M.
- Renaissance Technologies fully exited Apple in Q3 2013, selling an estimated $283M.
- Renaissance Technologies's ten largest holdings make up 11% of its $41.2B portfolio in Q3 2013.
- Renaissance Technologies opened 439 new positions and closed 412 in Q3 2013.
- Renaissance Technologies's portfolio value rose 8.1% quarter-over-quarter to $41.2B.
Based on Renaissance Technologies's 13F filing for Q3 2013, filed 13 Nov 2013.